Victor Cervera

Victor Cervera has a diverse work experience, starting in 2015. Victor began their career as a Scientific Researcher at the University of Helsinki, where they worked from January 2015 to June 2015. Victor then served as a Hospital Pharmacist at Hospital Clínico San Carlos, gaining experience in various pharmacy responsibilities from September 2015 to December 2015. Next, Victor worked as a Community Pharmacist at Farmacia Pintor Sorolla from December 2015 to January 2016. Victor also held the position of Scientific Researcher at Universidad Complutense de Madrid from July 2015 to February 2016.

In 2016, Victor joined TILT Biotherapeutics Ltd as a Marie Skłodowska-Curie PhD student in the VIRION consortium. This role allowed him to conduct research and translational activities related to cancer immunotherapy, with a focus on the industrial perspective. Victor remained with TILT Biotherapeutics Ltd until December 2018.

From 2018 to 2022, Victor held the position of Head of Immunology at TILT Biotherapeutics Ltd, where they continued their work in cancer immunotherapy. In March 2022, they were promoted to the role of Vice President of Business Development at the same company.

In 2021, Victor also became a Senior Researcher at the University of Helsinki, where they are currently employed.

Victor Cervera completed their education with a Doctor of Philosophy (PhD) degree in Immuno-Oncology from the University of Helsinki. Victor pursued this degree from 2016 to 2021. Prior to that, they obtained a Master of Pharmacy degree from the Universidad Complutense de Madrid, where they were enrolled from 2010 to 2016. No specific field of study is mentioned for their Master's degree.